Company news
Guobang Pharma Ltd. news in 2026
Guobang Pharma Ltd.'s news releases, calls and decks from 2026, newest first.
(605507)"Guobang Pharma Ltd."Announcement on Shareholdings of Top 10 Shareholders and Top 10 Shareholders Holding Unrestricted Shares Concerning Share Repurchase
November 3, 2026
(605507)"Guobang Pharma Ltd."Announcement on Initial Repurchase of Shares through Call Auction and Progress of Repurchase
November 1, 2026
(605507)"Guobang Pharma Ltd."Announcement on Share Repurchase Plan through Call Auction and the Repurchase Report
October 29, 2026
(605507)"Guobang Pharma Ltd."Announcement on Completion of Share Repurchase and Implementation Results of Repurchase
October 29, 2026
(605507)"Guobang Pharma Ltd."Report for Q3 2026
October 23, 2026
(605507)"Guobang Pharma Ltd."Announcement on Convening the Q3 2026 Performance Briefing
October 23, 2026
(605507)"Guobang Pharma Ltd."Announcement on Change of Name and Other Industrial and Commercial Information of the Controlling Shareholder and Completion of Industrial and Commercial Registration Changes
October 16, 2026
(605507)"Guobang Pharma Ltd."Announcement on Progress in Repurchasing Shares
October 8, 2026
Announcement on Obtaining New Veterinary Drug Registration Certificate by Wholly-owned Subsidiary
September 29, 2026
Announcement on a Wholly-owned Subsidiary's Product DMG-PEG2000 Passing the Joint Review and Approval with Its Formulation by the CDE
September 15, 2026
Announcement on Convening the 2026 Semi-annual Performance Briefing
September 9, 2026
Semi-annual Report for 2026
July 31, 2026
Announcement on Progress in Repurchasing Shares
July 1, 2026
Announcement on the Repurchased Company Shares Reaching 1% and Repurchase Progress
June 24, 2026
Announcement on Progress in Repurchasing Shares
June 16, 2026
Announcement on Wholly-owned Subsidiary Participating in Equity Investment Fund
June 15, 2026
Announcement on Initially Repurchasing the Company's Shares through Auction
June 3, 2026
Announcement on Shareholding of Top 10 Shareholders and Top 10 Shareholders Without Sales Limit Concerning Shares Repurchase
June 1, 2026
Announcement on Plan for Repurchasing Shares through Call Auction and Repurchase Report
May 29, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 21, 2026
Announcement on Progress in Wholly-owned Subsidiary Participating in the Establishment of Equity Investment Fund
May 18, 2026
Announcement on the Acquisition of Approval Documents for Veterinary Drug Product Approval Number by the Wholly-owned Subsidiary
April 24, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 23, 2026
"Corporate Value and Return Enhancement" Action Plan 2026
April 15, 2026
Announcement on Investment in a New Project by the Company’s Wholly-owned Subsidiary
March 27, 2026
Announcement on Progress and Implementation Result of Shares Repurchase and Share Changes
March 2, 2026
Announcement on Listing and Circulation of Partial Restricted Shares in Initial Public Offering
January 27, 2026